تخطي إلى المحتوى الرئيسي

المهنيين الطبيين

تم تصميم مقالات المراجع المهنية لاستخدامها من قبل المتخصصين في الرعاية الصحية. يتم كتابتها بواسطة أطباء من المملكة المتحدة وتستند إلى الأدلة البحثية والإرشادات البريطانية والأوروبية. قد تجد أحد مقالاتنا مقالاتنا الصحية أكثر فائدة.

See also the separate articles on التاريخ والفحص العصبي, الفحص العصبي للأطراف السفلية و الفحص العصبي للأطراف العلوية.

What are polyneuropathies?

Polyneuropathies are the most common type of disorder of the peripheral nervous system in adults, especially the elderly, with an estimated prevalence of 5-8%, depending on age.1

Most polyneuropathies are chronic and usually develop over several months. Three main patterns of polyneuropathy can be distinguished and each has a different differential diagnosis:

  • Acute symmetrical peripheral neuropathy.

  • Chronic symmetrical peripheral neuropathy.

  • Multiple mononeuropathy.

Both peripheral and cranial nerves are affected, either by axonal degeneration (nerve becomes electrically inert within one week) or demyelination, which initially leaves the axon intact and results in blockage or slowing of conduction.

Symptoms of polyneuropathies (presentation)

Patients with polyneuropathy may present with altered sensation, pain, weakness or autonomic symptoms. Acute symmetrical polyneuropathy (eg, متلازمة غيلان باريه) is uncommon.

Sensory polyneuropathy2

  • In sensory polyneuropathy, usually, the feet are affected first.

  • Paraesthesiae, numbness, burning pain, and loss of vibration sense and position sense are prominent. Muscle wasting may occur.

  • The sensory neuropathy may be subacute with ataxia caused by loss of sense of posture.

الاعتلال العصبي اللاإرادي3

  • Polyneuropathy often affects the autonomic nervous system.

  • Typical symptoms are constipation, loss of bowel or bladder control and orthostatic hypotension. The skin may become pale and dry and sweating may be reduced.

Hereditary polyneuropathy4

Hereditary causes of polyneuropathy may also cause hammer toes, high arches and scoliosis.

التشخيص التفريقي

The cause of chronic polyneuropathy is often unknown. The most common causes of peripheral neuropathy are:

Others causes include:

Diagnosing polyneuropathies (investigations)7

Initial tests include:

  • Urine: glucose, protein.

  • Haematology: FBC, erythrocyte sedimentation rate (ESR), vitamin B12, folate.

  • Biochemistry: fasting glucose, renal function, liver function and thyroid function.

Further investigations will depend on the outcome of clinical assessment and initial investigation results:

  • Neurophysiology testing with assessment of distal and proximal nerve stimulation; electrophysiological procedures are helpful in determining the pathological process which may be either an axonopathy, a myelinopathy or a neuronopathy.8

  • Biochemistry: serum protein electrophoresis, serum angiotensin-converting enzyme.

  • Immunology: antinuclear factor, anti-extractable nuclear antigen antibodies (anti-Ro, anti-La), antineutrophil cytoplasmic antigen antibodies.

  • Urine: Bence-Jones protein.

  • Cerebrospinal fluid: cells, protein, immunoglobulin oligoclonal bands.

  • Immunology: anti-HIV antibodies, antineuronal antibodies (Hu, Yo), antigliadin antibodies, serum angiotensin-converting enzyme, antiganglioside antibodies, antimyelin-associated glycoprotein antibodies.

  • Search for carcinoma, lymphoma or solitary myeloma.

  • Molecular genetic tests - eg, for Charcot-Marie-Tooth syndrome.

  • Nerve biopsy may be required.

Management of polyneuropathies

The initial assessment of the diagnosis and underlying cause is usually performed in secondary care. Re-referral may be indicated at a later stage if there is a significant deterioration in symptoms or an alteration in the presentation suggesting a further assessment is required.

Acute multiple mononeuropathy requires urgent assessment, as the most common cause is vasculitis. Prompt treatment with steroids, with or without cyclophosphamide, may prevent further irreversible nerve damage.

  • Preventative and palliative treatments include foot care, weight reduction, sensible footwear and foot orthoses.

  • Patients with severe leg weakness may need walking aids.

  • Simple wrist splints can help weak wrist extension.

  • Disabled patients require help from a multidisciplinary team including an occupational therapist and a physiotherapist.

دوائي

  • Specific treatment depends on the cause.

  • Good control of glucose and blood pressure in patients with السكري may improve or at least slow the progress of neuropathy.

  • Chronic inflammatory demyelinative polyneuropathy is treatable with corticosteroids, intravenous immunoglobulin, plasma exchange and some immunosuppressant drugs.9

  • Multifocal motor neuropathy responds to intravenous immunoglobulin, and possibly immunosuppressant drugs.10

  • No specific treatment is available for chronic idiopathic axonal polyneuropathy.

  • Painful neuropathy is difficult to treat. The most useful drugs are amitriptyline, duloxetine, gabapentin or pregabalin.11

Complications of polyneuropathies

  • With loss of sensation, recurrent injury to joints may lead to permanent joint destruction (Charcot joint).12

  • May lead to disability, social isolation or loss of independence, especially in the elderly.

تحديثات حصرية لمتخصصي الرعاية الصحية

ابقَ على اطلاع بأحدث التحديثات السريرية، والرؤى المهنية، والإرشادات المستندة إلى الأدلة. تقوم نشرة Patient Pro الإخبارية بتجميع محتوى أساسي لمتخصصي الرعاية الصحية - يتم تسليمه مباشرة إلى بريدك الوارد.

يرجى إدخال عنوان بريد إلكتروني صالح

من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.

قراءة إضافية ومراجع

  1. Sommer C, Geber C, Young P, et al; Polyneuropathies. Dtsch Arztebl Int. 2018 Feb 9;115(6):83-90. doi: 10.3238/arztebl.2018.083.
  2. Freeman R, Gewandter JS, Faber CG, et al; Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria. Neurology. 2020 Dec 1;95(22):1005-1014. doi: 10.1212/WNL.0000000000010988. Epub 2020 Oct 14.
  3. Vinik AI, Erbas T; الاعتلال العصبي اللاإرادي السكري. دليل علم الأعصاب السريري. 2013;117:279-94. doi: 10.1016/B978-0-444-53491-0.00022-5.
  4. Kramarz C, Rossor AM; Neurological update: hereditary neuropathies. J Neurol. 2022 Sep;269(9):5187-5191. doi: 10.1007/s00415-022-11164-1. Epub 2022 May 21.
  5. Brizzi KT, Lyons JL; Peripheral nervous system manifestations of infectious diseases. Neurohospitalist. 2014 Oct;4(4):230-40. doi: 10.1177/1941874414535215.
  6. Cojocaru IM, Cojocaru M, Silosi I, et al; Peripheral nervous system manifestations in systemic autoimmune diseases. Maedica (Buchar). 2014 Sep;9(3):289-94.
  7. Mirian A, Aljohani Z, Grushka D, et al; Diagnosis and management of patients with polyneuropathy. CMAJ. 2023 Feb 13;195(6):E227-E233. doi: 10.1503/cmaj.220936.
  8. Gwathmey KG, Pearson KT; Diagnosis and management of sensory polyneuropathy. BMJ. 2019 May 8;365:l1108. doi: 10.1136/bmj.l1108.
  9. Said G, Krarup C; Chronic inflammatory demyelinative polyneuropathy. Handb Clin Neurol. 2013;115:403-13. doi: 10.1016/B978-0-444-52902-2.00022-9.
  10. Muley SA, Parry GJ; Multifocal motor neuropathy. J Clin Neurosci. 2012 Sep;19(9):1201-9. doi: 10.1016/j.jocn.2012.02.011. Epub 2012 Jun 27.
  11. الألم العصبي - الإدارة الدوائية: الإدارة الدوائية للألم العصبي لدى البالغين في البيئات غير المتخصصة; إرشادات NICE السريرية (نوفمبر 2013، آخر تحديث سبتمبر 2020)
  12. Galanis N, Kyriakou A, Delniotis I, et al; Charcot arthropathy: The diagnostic dilemma of a painless, destructive joint. Clin Case Rep. 2019 Dec 11;8(1):224-225. doi: 10.1002/ccr3.2603. eCollection 2020 Jan.

تاريخ المقال

تمت كتابة المعلومات على هذه الصفحة ومراجعتها من قبل أطباء مؤهلين.

صيدلية إلكترونية وعلاجات وخدمات صحية

وصول بسيط إلى العلاجات والخدمات الصحية الموثوقة عبر الإنترنت.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment